We're excited to announce positive initial results in the development of improved in vitro lung adenocarcinoma models with our partners Cell&Soft.
2020 is coming to an end and we would like to wish you all a wonderful holiday and a Happy New Year!
We are glad to participate in this year's Cancer Stem Cells: Impact on Treatment digital event. Tune in to listen to our talk discussing our #TissueSpec® #extracellularma trix substrates and how they are being used as a tool to investigate #cancer #invitro.
We are proud to be highlighted in this article, and to be a part of the rapidly growing New York City biotech landscape.https:// www.fiercebiotec h.com/ sponsored/ from-conquering- covid-19-to-cur ing-cancer-new- york-city-chart s-future-life-s ciences
In a recent study we show differential responses to #Tamoxifen treatment in #TissueSpec® #ECM #Hydrogels. When cells are embedded in TissueSpec® Lung and Bone ECM Hydrogels they exhibit higher resistance than when embedded in TissueSpec® Liver ECM Hydrogel, Matrigel and plastic. This observation is...
Our recently launched #compoundtesting services IN MATRICO® for #liver #fibrosis incorporate human liver… https://t.co/VSis66jZ2L
Utilizing 3D human lung #ECM technology, Xylyx Bio offers #compoundtesting services #INMATRICO® for physiologically… https://t.co/CvSxpfUWst
In our recently published application note we discuss how our human fibrotic #ECM substrates recreate the fibrotic… https://t.co/K8lEKCb2Z2
Our new website highlights the revolutionary IN MATRICO™ products and services that we offer. Learn how our technol… https://t.co/9KIdMmY1rB
Join us on September 30th to learn about how our #TissueSpec® #Bone, #Liver, and #Lung #extracellularmatrix substra… https://t.co/dRIlVuvlnp
Similar Businesses
